Transcript Highlights:

• Question of the author. Do you yield, Senator? Of course I yield. Thank you.
• To ask questions of the author. Senator Hughes, do you yield?
• Questions of the author of the amendment. Senator Hughes do you yield?
• I have a question to the author of the amendment. Senator Hughes, do you yield?
• I mean, to the author, is there objection? There is objection. Secretary will call the. for all.

Bills: SJR57, SCR8, SB8, SB14, SB24, SB108, SB112, SB125, SB213, SB251, SB315, SB318, SB371, SB378, SB379, SB472, SB487, SB502, SB513, SB565, SB621, SB650, SB689, SB707, SB710, SB761, SB763, SB815, SB854, SB875, SB896, SB916, SB925, SB958, SB961, SB965, SB973, SB987, SB990, SB995, SB1006, SB1018, SB1019, SB1024, SB1026, SB1146, SB1194, SB1198, SB1253, SB1330, SB1343, SB1362, SB1379, SB1497, SB1498, SB1527, SB1532, SB1547, SB1596, SJR36, SJR12, SJR57, SCR22, SCR12, SCR8, SB565, SB765, SB62, SB666, SB707, SB888, SB687, SB847, SB1248, SB14, SB1006, SB504, SB925, SB995, SB857, SB305, SB296, SB284, SB815, SB1379, SB1497, SB1499, SB1498, SB241, SB304, SB621, SB1023, SB1024, SB686, SB112, SB371, SB204, SB609, SB670, SB502, SB850, SB854, SB413, SB1362, SB1346, SB1033, SB1220, SB1073, SB810, SB987, SB1539, SB447, SB875, SB406, SB985, SB965, SB1119, SB1505, SB24, SB1194, SB1253, SB1215, SB1532, SB1302, SB856, SB650, SB583, SB673, SB213, SB681, SB1172, SB1252, SB378, SB1343, SB608, SB487, SB955, SB957, SB988, SB990, SB1019, SB1021, SB1120, SB251, SB958, SB761, SB541, SB315, SB379, SB1018, SB1737, SB266, SB1415, SB1527, SB125, SB599, SB1330, SB53, SB916, SB896, SB1352, SB973, SB785, SB710, SB472, SB1450, SB1502, SB1566, SB414, SB1062, SB1547, SB961, SB1038, SB513, SB578, SB711, SB746, SB942, SB1404, SB1448, SB1738, SB108, SB8, SB318, SB507, SB533, SB689, SB1026, SB1349, SB1355, SB1433, SB1434, SB1596, SB1403, SB1198, SB1146, SB763, SB667, SB1059, SB617, SB1567, SB503, SJR37, SB16, SB310, SB311, SB396, SB505, SB1209, SB1210, SB1470, SB264, SB924, SB1029, SB1185, SB1202, SB1358, SB1364, SB1569, SB1697, SB1376, SB1228, SB519, SB878, SB1350, SB462, SB1535, SB827, SB1585, SB207, SB1207, SB1619, SB1396, SB920, SB1484, SB1273, SB1741

Keywords: central bank digital currency, CBDC, Federal Reserve, digital dollar, digital currency, cashless payments, financial privacy, cybersecurity, government surveillance, financial surveillance, money laundering, terrorism financing, illicit finance, banking policy, monetary policy, payments system, commercial banks, Texas Legislature, concurrent resolution, federal reserve digital currency

Transcript Highlights:

• Senate Bill 1153 by Hughes relaying the authority of the Texas Department of Motor Vehicles to take an
• Senate Bill 1165 by Blanco relating to the authority of certain counties to regulate.
• Senate Bill 1174 by Alvarado relating to the administration of non-prescription medications to certain
• Operative to business and commerce, Senate Bill 1252 by Schwartner, relating to the authority of the
• Senate Bill 1274 by Menendez relating to prior authorization for prescription drug benefits related to

Bills: SJR36, SJR3, SB616, SB565, SB384, SB5, SJR52, SJR53, SJR54, SJR55, SCR18, SCR19, SCR22, SB27, SB29, SB35, SB1151, SB1152, SB1153, SB1154, SB1155, SB1156, SB1157, SB1158, SB1159, SB1160, SB1161, SB1162, SB1163, SB1164, SB1165, SB1166, SB1167, SB1168, SB1169, SB1170, SB1171, SB1172, SB1173, SB1174, SB1175, SB1176, SB1177, SB1178, SB1179, SB1180, SB1181, SB1182, SB1183, SB1184, SB1185, SB1186, SB1187, SB1188, SB1189, SB1190, SB1191, SB1192, SB1193, SB1194, SB1195, SB1196, SB1197, SB1198, SB1199, SB1200, SB1201, SB1202, SB1203, SB1204, SB1205, SB1206, SB1207, SB1208, SB1209, SB1210, SB1211, SB1212, SB1213, SB1214, SB1215, SB1216, SB1217, SB1218, SB1219, SB1220, SB1221, SB1222, SB1223, SB1224, SB1225, SB1226, SB1227, SB1228, SB1229, SB1230, SB1231, SB1232, SB1233, SB1234, SB1235, SB1236, SB1237, SB1238, SB1239, SB1240, SB1241, SB1242, SB1243, SB1244, SB1245, SB1246, SB1247, SB1248, SB1249, SB1250, SB1251, SB1252, SB1253, SB1254, SB1255, SB1256, SB1257, SB1258, SB1259, SB1260, SB1261, SB1262, SB1263, SB1264, SB1265, SB1266, SB1267, SB1268, SB1269, SB1270, SB1271, SB1272, SB1273, SB1274, SB1275, SB1276, SB1277, SB1278, SB1279, SB1280, SB1281, SB1282, SB1283, SB1284, SB1285, SB1286, SB1287, SB1288, SB1289, SB1290, SB1291, SB1292, SB1293, SB1294, SB1295, SB1296, SB1297, SB1298, SB1299, SB1300, SB1301, SB1302, SB1303, SB1304, SB1305, SB1306, SB1307, SB1308, SB1309, SB1310, SB1311, SB1312, SB1313, SB1314, SB1315, SB1316, SB1317, SB1318, SB1319, SB1320, SB1321, SB1322, SB1323, SB1324, SB1325, SB1326, SB1327, SB1328, SB1329, SB1330, SB1331, SB1332, SB1333, SB1334, SB1335, SB1336, SB1337, SB1338, SB1339, SB1340, SB1341, SB1342, SB1343, SB1344, SB1345, SB1621, SJR57

Keywords: dementia, Alzheimer's disease, Parkinson's disease, research funding, state budget, prevention, healthcare, medical research, Dementia Prevention and Research Institute, aquifer, water management, Edwards Aquifer, sustainability, regulatory framework, SB 565, Texas Water Code, TCEQ, Texas Commission on Environmental Quality, compliance agreement, enforcement suspension

Transcript Highlights:

• We responded to 1,400 audits, which comprised 2,900 prescriptions.
• They see $2,802.40 for the prescription.
• Are you saying that you lose $30 or $40 per prescription?
• Prescription drugs, two prescription drugs that the FDA has approved that are very expensive.
• have any prescription coverage that's part D right now.

Bills: HB1464, HB1635, HB2516, HB3317, HB3502, HB4012, HB4268, HB4386, HB4877, SB916

Keywords: prescription drugs, drug pricing, pharmacy benefits, health insurance, health benefit plan, insurer, HMO, self-insured employer, public employer, school district, county, municipality, university system, higher education, retirees, dependent coverage, stop-loss coverage, bulk purchasing, group purchasing, purchasing pool

Transcript Highlights:

• , to provide for applicability to requests for authorizations for prescription drugs, and to provide
• , to provide for applicability to request for authorizations for prescription drugs, and to provide for
• Two out of the three have said that authorization for prescription drugs should not be part of what can
• This does not in any way take away the right of the insurance company to pre-authorize prescription drugs
• quickly authorized.

Bills: HB282, HB293, HB390, HB456, HB460, HB561, HB819, HB1023, HB1047, HB1101

Keywords: employment discrimination, criminal history, rehabilitation, hiring process, human rights, gender identity, sexual orientation, workplace equality, labor rights, domestic abuse, unpaid leave, employee rights, workplace protection, mental health, survivor support, workers' compensation, employment benefits, claims process, fraud prevention, legal petition

Transcript Highlights:

• You were required to get prescription filled through the mail prescription filled through the mail prescription
• And let me state prescriptions. And let me state prescriptions.
• and for prescription prescriptions and for prescription prescriptions and for prescription medication
• prescription medicine was prescription prescription medicine was prescription prescription medicine
• drugs. prescription drugs. prescription drugs.

Bills: SCR 13, SCR 24, SB 1, SB 12, SB 15, SB 17, SB 24, SB 57, SB 65, SB 213, SB 371, SB 372, SB 378, SB 379, SB 388, SB 400, SB 402, SB 427, SB 495, SB 499, SB 502, SB 509, SB 535, SB 583, SB 610, SB 621, SB 650, SB 706, SB 740, SB 840, SB 854, SB 856, SB 875, SB 893, SB 918, SB 925, SB 974, SB 995, SB 1006, SB 1018, SB 1025, SB 1061, SB 1073, SB 1106, SB 1121, SB 1194, SB 1252, SB 1253, SB 1268, SB 1300, SB 1343, SB 1362, SB 1447, SJR 36, SJR 12, SJR 57, SCR 25, SCR 22, SCR 12, SCR 24, SCR 8, SB 565, SB 372, SB 765, SB 62, SB 666, SB 707, SB 888, SB 687, SB 847, SB 1248, SB 740, SB 14, SB 1006, SB 504, SB 925, SB 1121, SB 995, SB 857, SB 305, SB 296, SB 284, SB 815, SB 1379, SB 1300, SB 1497, SB 1499, SB 1498, SB 1061, SB 65, SB 241, SB 304, SB 402, SB 499, SB 621, SB 974, SB 1023, SB 1024, SB 1025, SB 1106, SB 686, SB 112, SB 371, SB 204, SB 400, SB 609, SB 1447, SB 670, SB 502, SB 427, SB 850, SB 854, SB 413, SB 1555, SB 1362, SB 1346, SB 1033, SB 1220, SB 1073, SB 810, SB 987, SB 1539, SB 893, SB 447, SB 875, SB 406, SB 509, SB 985, SB 965, SB 1119, SB 1505, SB 24, SB 57, SB 1194, SB 1253, SB 1215, SB 1532, SB 1268, SB 1302, SB 856, SB 650, SB 583, SB 673, SB 840, SB 213, SB 681, SB 1172, SB 1252, SB 378, SB 610, SB 918, SB 1343, SB 608, SB 487, SB 955, SB 957, SB 988, SB 990, SB 1019, SB 1021, SB 1120, SB 251, SB 958, SB 535, SB 761, SB 1, SB 541, SB 315, SB 379, SB 1018, SB 1737, SB 266, SB 1415, SB 57, SB 499, SB 974, SB 1025, SB 1061, SB 1268, SR 302, SR 303, SR 304, SR 305, SB 30, SB 1333, SB 1666, SB 30, SB 1333, SB 1666

Keywords: water rights, treaty compliance, Rio Grande, agriculture, drought, international water, Texas water supply, Texas, Israel, trade, investment, partnership, economic ties, technological innovation, bilateral relations, appropriations, budget, state funding, education, healthcare

Transcript Highlights:

• We do not have any questions for the author or for you.
• 1868.2, the authorization of co-pay assistance.
• Prescription drug costs at Louisiana Blue, if you look at the...
• Joy going to pay about $100 more per year per prescription? And he said yes. Okay.
• I will say this: the authors asked me to run this bill on the floor.

Bills: HB591, HB765, HB826, HB870, HB938, HB1151, HB1162, HB1176, HB1196, HB1236, HB1241

Keywords: family leave, insurance, paid leave, employment benefits, caregiver support, liability insurance, coverage defenses, direct action, judgment enforcement, legal procedures, insurance referrals, compensation, non-licensed agents, consumer protection, insurance products, HB 870, Act 907, Louisiana insurance, health insurance, prescription drugs

Transcript Highlights:

• <00:35:36.520> this of someone who actually authored this of someone who actually authored
• to lowering the cost of prescription to lowering the cost of prescription drugs<00:50:14.000>
• prescription drugs. prescription drugs.
• affordable prescription drugs. affordable prescription drugs.
• prescription drug. prescription drug.

Keywords: 981, all

Summary: The Senate met with a quorum, approved the journal, and then proceeded out of order to consider Senate Joint Resolution 20, recognizing April 9, 2026, as Home Education Day in Colorado. Senator Pelton spoke in strong support of home education, describing it as a parent-led choice that benefits students and families. The resolution was adopted on a 30-0 vote, and the current roll was added as co-sponsors. The chamber then took up the consent calendar and passed House Bill 1229, House Bill 1244, and Senate Bill 153. HB 1229, which concerns the human-animal bond as a social determinant of health, drew three no votes from Senators Pelton, Zamora Wilson, and Baeza; the other two measures passed unanimously. The Senate also laid over third reading of bills until Friday, April 10. In Committee of the Whole, senators considered Senate Bill 72, which increases criminal penalties for assaultive conduct involving a motor vehicle and adds causing death with a motor vehicle to criminally negligent homicide. The committee adopted the report and advanced the bill on second reading. Later, the chamber laid over Senate Bill 134 and House Bill 1084 until April 10, and then took up Senate Bill 140, which would exempt certain rare disease and plasma therapies from review by the Prescription Drug Affordability Review Board. Sponsors and supporters argued the bill protects access for patients with rare diseases and prevents harm to treatment development, while opponents said it would weaken the PDAB’s affordability work and was too broad. Senators Weisman and Gonzales spoke against the bill, with Weisman citing concerns about the federal definition used and Gonzales defending the PDAB’s role in lowering drug costs; the debate continued in the transcript without a final vote shown.

Transcript Highlights:

• This bill does not add anything to the cost of a prescription.
• It only defines how a prescription must be.
• These bills impose a $10.64 fee on every prescription filled. $10.64 fee on every prescription filled
• Last year, they filled over 80% of the prescriptions. States.
• By law, you can't fill the prescription unless the pharmacist fills it. the prescription unless the pharmacist

Keywords: 923, senate, all

Transcript Highlights:

• under this bill, will the physician be able to give ...prescription.
• Under this bill, will the physician be able to give me a paper prescription?
• I could not have a paper prescription. Thank you, Madam Chair.
• So does this bill require every single doctor to have, to issue electronic prescriptions?
• I just wanted to express that in the vast majority of the time we use electronic prescriptions.

Summary: The committee took up a large health policy agenda. SB 1568 on electronic prescribing was explained as a federal conformity measure, but members raised concerns about preserving patients’ ability to obtain paper prescriptions and about exemptions for emergency, hospice, and other situations. Emergency physicians testified in support of e-prescribing but asked for flexibility, and the bill was reported favorably despite Senator Harrell’s opposition. SB 1606 on patient access to records sought to standardize record-production timelines and require electronic delivery when available; after an amendment correcting a drafting error, the bill drew concerns about HIPAA, behavioral health confidentiality, and the distinction between personal and legal representatives, and it was reported unfavorably as a committee substitute. The committee then approved SB 1346 on fentanyl testing, with a technical amendment, to require hospitals and campus emergency departments to test for fentanyl in urine testing for suspected overdose or poisoning. SB 1224 on administration of controlled substances by paramedics was amended to clarify language and reported favorably. SB 656 on health care billing and collection activities was substantially revised by strike-all amendment to allow sale of medical debt to third parties under new limits, including no interest or fees and return of debt if charity care applies; it was reported favorably as a committee substitute. SB 68 expanded health facilities authority financing to include not-for-profit LLCs and parent companies, and SB 524 added Duchenne muscular dystrophy to the newborn screening panel; both were reported favorably. Later, the committee approved SB 1842 on out-of-network referrals after multiple amendments, requiring providers to verify network participation at the point of service and notify patients in writing, though several members and physicians warned it could burden providers and increase workload. The committee also advanced proposed committee bill SB 7028, which revises the Casey DeSantis Cancer Research Program, adds oversight and reporting requirements, creates a pediatric cancer research incubator, and establishes the Bascom-Palmer VisionGen initiative; cancer center representatives testified in strong support, and the bill was reported favorably as a committee bill. SB 172 on specialty titles and designations was amended to clarify enforcement and was reported favorably after supporters said it would prevent misleading use of specialist titles, while opponents argued it could confuse practitioners’ titles. Finally, SB 1690 on surrendered infants was reported favorably after supporters said it would codify and expand safe-haven baby box procedures and opponents raised safety concerns about the devices. The committee also noted SB 1606 remained pending for reconsideration next week before adjourning.

Transcript Highlights:

• This is the House File 2242, the medical assistance single PBM prescription drug management model authorizing
• drug manu management model prescription drug manu management model authorizing<01:03:18.680> language
• about 60 or 65% of those prescriptions about 60 or 65% of those prescriptions that<01:10:10.080>
• <01:10:20.000> are<01:10:20.239> many<01:10:20.560> prescriptions prescriptions
• are many prescriptions prescriptions are many prescriptions that<01:10:21.840> are<01:10:22.000

Keywords: 1183, house

Transcript Highlights:

• We've had to go back to our doctor multiple times just to get a new prescription or a partial prescription
• Allowing prescriptions to be transferred between pharmacies solves this. It reduces stress.
• We're just trying to have a prescript of measure here to help prevent inadvertent loss of tax savings
• I've been told it was too soon to refill my prescription.
• The cost to buy it over the counter without a prescription is over $300, which is absurd.

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a hearing with Chair Jamie Murphy and Senate co-chair Senator Feeney presiding. Members asked witnesses to keep testimony to three minutes and noted that written testimony could still be submitted. The committee heard testimony on several health insurance and pharmacy-related bills, including a proposal to allow controlled prescriptions to be transferred between pharmacies within the same chain, legislation affecting health savings account (HSA)-compatible plans and future insurance mandates, a bill on small business health insurance incentives, and H. 1212 on emergency insulin access. Several parents and patients testified in support of emergency insulin access, describing severe diabetes emergencies, diabetic ketoacidosis, prescription delays, and the need for pharmacists to dispense insulin in urgent situations when doctors or insurers are unavailable. A parent also described the burden of repeatedly obtaining new prescriptions for ADHD medication when pharmacies are out of stock. Witnesses supporting the HSA bill argued that state coverage mandates can unintentionally disqualify HSA-qualified plans and that the bill would preserve tax advantages for enrollees while avoiding repeated legislative fixes. A representative of the Retailers Association supported the small business health insurance incentives bill, saying it could help retain small employers in the merged market by allowing carriers to offer financial incentives tied to cooperative purchasing and utilization efforts. One witness, Kathleen Demarest, testified against a co-pay assistance restriction, saying a state rule had unexpectedly cut off her drug assistance before a generic was actually available, leaving her with very high out-of-pocket costs. Committee members asked a few clarifying questions about HSAs, insulin dispensing, and school support for diabetes care. After all scheduled witnesses had testified and no additional testimony was offered, the committee voted to close the hearing.

Transcript Highlights:

• believe. uh 1574 which would authorize believe. uh 1574 which would authorize the<00:52:08.559><
• We live, bank, shop, prescriptions.
• more prescriptions filled below cost. more prescriptions filled below cost.
• room take at least one prescription room take at least one prescription medication.<01:00:01.920
• America and the prices of prescription America and the prices of prescription drugs<01:09:08.159

Keywords: 1187, senate, all

Transcript Highlights:

• Is that something that this is giving pharmacists independent authority to then take the prescription
• Is that something that this is giving pharmacists independent authority to then take the prescription
• Is that something that this is giving pharmacists independent authority to then take the prescription
• Is that something that this is giving pharmacists independent authority to then take the prescription
• Is that something that this is giving pharmacists independent authority to then take the prescription

Bills: HB0143, HB0129

Keywords: health care providers, free speech, discrimination, governmental agencies, civil remedies, physician access, internationally trained physicians, medical licensing, provisional license, healthcare workforce, 916, all

Transcript Highlights:

• Members, questions or comments for the author, Senator?
• Members, questions or comments for the author, Senator?
• <00:15:55.160> Senator for the author Senator for the author Senator how<00:15:57.600>
• <00:41:28.440> is prescription is prescription is for<00:41:31.000> senat<00:41:31.319>
• :11.000> prescription<00:49:11.520> drugs<00:49:12.079> currently agree that prescription

Keywords: 1187, senate, all

Transcript Highlights:

• And um the number of prescriptions.
• intense, they give you a prescription intense, they give you a prescription and<01:06:42.880>
• appropriate nonopioid prescription drug. appropriate nonopioid prescription drug.
• <01:33:51.280> prescription.
• prescript prescription. prescript prescription.

Keywords: 981, all

Summary: The Senate convened with a quorum, approved the previous day’s journal, and received a long list of bill status reports and enrollments. It also introduced Senate Bill 168, concerning reporting of money handled by legislative caucuses, and Senate Bill 169, a non-substantive revision bill for the Colorado Revised Statutes. The chamber then agreed to proceed out of order for moments of personal privilege and recognized the Denver and Colorado Springs chapters of The Links, Incorporated for Lynx Day at the Capitol. The Senate next took up a special-order consent calendar containing House Bill 1110, Senate Bill 78, and Senate Bill 151. All three committee reports and the bills themselves were adopted without objection, and the Committee of the Whole report was later adopted by a 35-0 vote. As reported, Senate Bill 78 was amended, Senate Bill 151 passed second reading and was ordered engrossed, and House Bill 1110 was amended, passed second reading, and ordered revised for third reading and final passage. The chamber then moved to special orders on Senate Bill 6 and Senate Bill 15, and the transcript focuses mainly on Senate Bill 6, which would require health insurers to offer at least one non-opioid pain medication option. Supporters argued the bill would expand access to safer pain-management alternatives, reduce opioid addiction, and encourage innovation; several members shared personal or professional experiences with opioid harms. Opponents argued the bill would mandate newer, more expensive drugs when less costly alternatives already exist and could raise health care costs. The debate continued in the excerpt, but no final vote on Senate Bill 6 is shown here.

Transcript Highlights:

• Expanding limited prescriptive and diagnostic authority for pharmacists allows us to better use an existing
• Expanding limited prescriptive and diagnostic authority for pharmacists allows us to better use an existing
• Expanding limited prescriptive and diagnostic authority for pharmacists allows us to better use an existing
• In closing, empowering pharmacists with limited prescriptive and diagnostic authority is a practical,
• In closing, empowering pharmacists with limited prescriptive and diagnostic authority is a practical,

Bills: HB1621, HB1624, HB1623, HB1622, HB1625, HB1626, HB1627, HCR3038

Keywords: presidential physical fitness test, physical education, fitness assessment, student fitness, school curriculum, graduation requirements, elementary school, middle school, high school, public schools, nonpublic schools, superintendent of public instruction, exceptions, disability accommodations, North Dakota studies, computer science, cybersecurity, health education, concept-based fitness class, school standards

Summary: The North Dakota House convened in special session with prayer, roll call, and a quorum present, then took up several rural health-related bills. Senate Bill 2401, as amended, required physicians to complete one hour of continuing education in nutrition and metabolic health each renewal cycle and also added language allowing criminal history background checks for the Board of Occupational Therapy Practice. Supporters emphasized the role of nutrition in reducing chronic disease, and the bill passed 92-0. The House then considered Senate Bill 2402, which expanded pharmacists’ limited prescriptive and therapeutic substitution authority for certain low-acuity conditions and clarified related lab-test and communication requirements. Members discussed examples such as motion sickness, cold sores, lice, hypoglycemia, COVID and flu testing, emergency access to medications and supplies, and limits excluding certain drug classes; the bill passed 91-1. Senate Bill 2403 created a temporary medical facility emergency operating loan option through the Bank of North Dakota for qualifying rural hospitals facing severe financial distress, with extensive debate over the targeted nature of the aid, anti-gifting concerns, repayment terms, and the hospital’s turnaround plan; it passed 80-12. Senate Bill 2404 appropriated funds for NDIT to address federal digital accessibility requirements and for the Public Service Commission’s litigation efforts related to transmission costs, with a backup loan authorization available if needed; it passed 92-0. At the close of the session, leaders thanked members and staff for their work on the rural health transformation package, a committee notified the Governor and the Senate that the House had completed its business, absent members were excused, and the House adjourned sine die.

Transcript Highlights:

• I'm proud to be a co-author along with you.
• And so with that, I would love to be able to be a co-author on this bill as well.
• We're grateful to the author for advancing this important issue.
• I want to thank the author for this bill.
• And that means under 1,000 treatment plans statewide were authorized.

Keywords: 988, house, all

Transcript Highlights:

• Kincart Jonsson: THANK YOU GOOD AFTERNOON , THANK YOU FOR ALLOWING ME TO PRESENT HB 697, THE PRESCRIPTION
• THE US BUYS 23% OF THE WORLDS PRESCRIPTION DRUGS BUT PAYS 62% OF THE WORLDWIDE COST.
• ACROSS FLORIDA FAMILIES ARE VIEWING THE STRAIN OF RISING PRESCRIPTION DRUG COSTS, THE PRICE ACT IS FOCUSED
• THE PRESCRIPTION DRUG SYSTEM OPERATES SORT OF LIKE THE MAFIA.
• LET OIR HAVE THE AUTHORITY.

Transcript Highlights:

• For the record, Evan Klein with the Health Care Authority.
• Prescription drug price transparency. Prescription drug price transparency.
• to administer a prescription drug price transparency program.
• The Prescription Drug Affordability Board is another board that we administer at the Health Care Authority
• The Prescription Drug Affordability Board's work is really an extension of some of the prescription drug

Summary: The committee began with an extended work session on the long-term care workforce. DSHS Assistant Secretary B. Rector described the new Home and Community Living Administration and outlined major workforce pressures: Washington had about 126,000 long-term care workers in 2022, with demand expected to outpace supply as the 85-plus population and dementia prevalence rise sharply. She emphasized that direct care workers are largely women, people of color, and immigrants, and that family caregivers are also a major part of the system. She highlighted recruitment and retention efforts funded through federal Money Follows the Person dollars, including high school training partnerships, a retention toolkit, transportation support, caregiver newsletters, tribal workforce navigators, and a remote caregiving pilot. Committee members asked about career pathways, technology use, and turnover drivers; Rector said wages, benefits, unstable hours, and workplace support are key issues and promised follow-up data. Aidan Swain of the Washington Health Care Association said skilled nursing and assisted living facilities face acute RN vacancies, wage pressures, and Medicaid reimbursement that does not cover costs, and urged modernization of training, better reimbursement, and continued support for facility-based care. Maddie Fouch of SEIU 775, representing about 55,000 caregivers, said low wages, weak benefits, lack of voice, and certification delays are driving turnover and shortages, and argued for higher compensation, better worker protections, and more transparent reimbursement. Catherine Smith of Behavioral Health Solutions described growing behavioral health needs in nursing homes, the role of expanded behavioral supports programs, and credentialing delays that slow hiring. No votes were taken; the panel was informational only. The second agenda item was an overview of the palliative care benefit work group report required by 2024 legislation. Nico Jansen of the Office of the Insurance Commissioner explained that the work group, convened with the Health Care Authority, studied a potential palliative care benefit for fully insured commercial plans and also Medicaid, PEBB, and SEBB. He said palliative care is a philosophy of care focused on symptom management, coordination, and support for serious illness, and is distinct from hospice because it can be provided alongside curative treatment. The actuarial analysis concluded that creating a new benefit would likely increase costs, estimating about a 28-cent per member per month increase overall and roughly $2.6 million to $4.5 million in annual state Medicaid costs if implemented in 2027. Jansen said the consultants did not find sufficient evidence to assume savings from avoided hospitalizations or long-term care, though several work group members disagreed and submitted response letters. Senators asked about other states, Medicare, health homes, and whether more research could clarify cost savings; OIC said some states, including Hawaii, are moving ahead with Medicaid palliative care benefits, Medicare covers some related services but not in the same way, and further evidence may emerge over time. OIC did not take a position on whether the Legislature should create the benefit. The final presentation covered health care price transparency tools in Washington and federally. Evan Klein and HCA Chief Data Officer Vishal Chaudry reviewed federal hospital and health plan transparency rules, the state all-payer claims database, prescription drug price transparency, the Health Care Cost Transparency Board, the Prescription Drug Affordability Board, and other reporting systems. They explained that the APCD contains claims from fully insured commercial plans, Medicaid, and public employee programs, but not self-insured employer data except for limited voluntary submissions. They also described how machine-readable files, consumer price tools, and aggregated dashboards are used, and noted that data limitations, delays, and complexity remain significant. Senators asked about voluntary self-insured participation, the role of AI in making data more usable, and whether transparency can really help consumers given access barriers and medical debt. HCA said AI is increasingly used by private entities to mine large transparency datasets, but state agencies still face limits in data access and analytic capacity. The committee did not take action; the session was informational and ended with a discussion of how transparency data might better inform policy and purchasing decisions in the future.

Transcript Highlights:

• So we are now on the committee substitute for SB 20: Prior Authorization and Prescription Drugs.
• So we believe in prior authorization.
• It does not remove prescription renewal every year.
• I will just point out a couple of things quickly: 94% of prescriptions issued do not involve prior authorization
• Prior authorization is approved. Okay, thank you for that.

Bills: SB101, SB21, HM52, HB132, SB14, SB20

Keywords: SB 101, Health Care Delivery and Access Act, repeal of repeal, sunset repeal, delayed repeal, health care, healthcare, access to care, medical services, provider regulation, state health law, New Mexico, SB 21, Medicare supplement, Medigap, open enrollment, guaranteed issue, birthday month enrollment, health insurance, insurance regulation